Literature DB >> 20467931

["Why is it always the heart which suffers from myocardial infarction?" The "Marburg hypothesis" of the pathogenesis of atherosclerosis].

In Frau Susanne Memoriam Klumpp1, Jürgen R Schaefer, Birgit Hufnagel, Bernhard Maisch, Josef Krieglstein.   

Abstract

There is no question that cholesterol, especially low-density lipoprotein (LDL) cholesterol, represent a major cardiovascular risk factor. The so-called lipid hypothesis has been proven by almost all epidemiologic studies, animal studies and, most importantly, by interventional studies with lipid-lowering drugs, especially statins. However, despite our better understanding of atherogenesis we cannot explain why atherosclerosis occurs most frequently and severely on coronary arteries rather than on other arteries such as those of the hands or feet. In addition, the "lipid hypothesis" is unable to explain the dramatic change in severity of a far more generalized atherosclerosis in patients suffering from diabetes mellitus.Recently, we studied the effects of fatty acids on endothelial integrity and found a dramatic increase in apoptosis under fatty acid exposition. Since it is well known that the heart depends highly on fatty acid delivery to cover its energy demand, we hypothesize that the heart becomes the victim of its energy demand. With the so-called Marburg hypothesis of atherogenesis we can explain the fact why especially the arteries of the heart show early atherosclerotic lesions, but also the fact why patients with diabetes develop more generalized atherosclerosis. Finding mechanisms to reduce the presence of fatty acids within the arterial wall might prevent plaque destabilization and could be a potential target in our fight against atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467931     DOI: 10.1007/s00059-010-3332-4

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  17 in total

Review 1.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 2.  The potential for novel anti-inflammatory therapies for coronary artery disease.

Authors:  Margaret A Cascieri
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

3.  Why does atherosclerosis occur where it occurs?

Authors:  J R Schaefer; S Klumpp; B Maisch; J Krieglstein
Journal:  Atherosclerosis       Date:  2005-04-26       Impact factor: 5.162

4.  Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease.

Authors:  Stefan Pilz; Hubert Scharnagl; Beate Tiran; Ursula Seelhorst; Britta Wellnitz; Bernhard O Boehm; Jürgen R Schaefer; Winfried März
Journal:  J Clin Endocrinol Metab       Date:  2006-04-04       Impact factor: 5.958

Review 5.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells.

Authors:  B Hufnagel; M Dworak; M Soufi; Z Mester; Y Zhu; J R Schaefer; S Klumpp; J Krieglstein
Journal:  Atherosclerosis       Date:  2005-01-26       Impact factor: 5.162

7.  Protein phosphatase type 2C active at physiological Mg2+: stimulation by unsaturated fatty acids.

Authors:  S Klumpp; D Selke; J Hermesmeier
Journal:  FEBS Lett       Date:  1998-10-23       Impact factor: 4.124

8.  Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.

Authors:  R J Jaumdally; G Y H Lip; J V Patel; R J MacFadyen; C Varma
Journal:  J Intern Med       Date:  2009-02-16       Impact factor: 8.989

9.  Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  David C Burgess; David Hunt; Liping Li; Diana Zannino; Elizabeth Williamson; Timothy M E Davis; Markku Laakso; Y Antero Kesäniemi; Jun Zhang; Raymond W Sy; Seppo Lehto; Stewart Mann; Anthony C Keech
Journal:  Eur Heart J       Date:  2009-09-29       Impact factor: 29.983

10.  Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.

Authors:  Frederic Mouquet; Delphine Rousseau; Valerie Domergue-Dupont; Alain Grynberg; Ronglih Liao
Journal:  Fundam Clin Pharmacol       Date:  2009-12-17       Impact factor: 2.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.